Facility factors | Individual factors | Pregnancy and referral factors | Delivery factors |
---|---|---|---|
District | Age | Parity | Sex of baby: male, female |
Type of facility where ANC was received: Health centre, polyclinic, community clinic, CHPS | Health Insurance coverage: Yes or No | Gestational age (Trimester) at first ANC visit: 1st, 2nd, rd | Gestational age at delivery: preterm (< 37 weeks) Term (37–40 weeks) Post term (> 40 weeks) |
Ownership of facility: Government or Private | Age | Number of ANC visits during pregnancy: 0, 1–3, 4+ | Any new-born complication at delivery: Yes or No |
Availability of sulfadoxine-pyrimethamine at pharmacy or dispensary: Yes or No | Highest educational attainment: none, primary, secondary, tertiary | History of previous pregnancy complication: Yes or No | Any maternal complication at developed at delivery: Yes or No |
Stock-out of sulfadoxine-pyrimethamine at pharmacy or dispensary within 6 months prior to study: Yes or No | Marital status: single, married, living together | Indication for referral is Malaria: Yes or No | Haemoglobin level at delivery: Normal (≥ 12 g/dl), mild anaemia (10.0–11.9 g/dl), moderate anaemia (9.9–7.0 g/dl) severe anaemia (< 7.0 g/dl) |
 | Employment status: Yes or No | Indication for referral is a pregnancy complication: Yes or No | Birth weight of baby: Low birth weight (< 2.5 kg) Normal weight (2.5–4.0 kg) Big baby (> 4.0 kg) |
 |  | Dose of IPTp received during pregnancy: 0, 1–3, 4–5, > 5; Adequate (NMCP/WHO): (5 +)/(3 +), Inadequate (NMCP/WHO): (< 5)/(< 3) |  |